Skip to main content

The pace of change in the drug landscape is applying unprecedented cost and complexity pressures on private benefit plans in Canada. Presenter Chris Goguen, Strategic Pharmaceutical Partnerships Lead for Medavie Blue Cross, explores the current and emerging trends that are driving up drug prices and offers targeted solutions to balance plan sustainability and access to care.

Click here to register


Share this post

About the Author
Chris Goguen

Chris joined Medavie Blue Cross in 2015, with 25 years of experience as a senior leader within the research-based pharmaceutical industry in Canada. With the majority of his career focussed on External Affairs, including strategy and relationship development with governments, private payers & other health stakeholders across Canada, Chris has developed expertise in drug pricing, access, negotiation and patient health management strategies. He has played a lead role in development and implementation of numerous disease [drug] management partnership programs, impacting both public and private health system outcomes.  

View all posts